Evidence for long-term hypercoagulopathy, but normalization of markers of extracellular matrix turnover, in patients with non-Hodgkin lymphoma

Leuk Lymphoma. 2015;56(8):2479-81. doi: 10.3109/10428194.2013.803227. Epub 2013 Jun 12.

Authors

Per O Iversen^{1

2}, Helene Negaard^{2

3}, Bjørn Østenstad³, Per M Sandset^{4

2

5}, Svein O Kolset¹

Affiliations

¹ a Department of Nutrition , Institute of Basic Medical Sciences.
² c Department of Hematology.
³ d Department of Oncology.
⁴ b Institute of Clinical Medicine, University of Oslo , Norway.
⁵ e Research Institute of Internal Medicine, Oslo University Hospital, University of Oslo , Norway.

PMID: 23656198
DOI: 10.3109/10428194.2013.803227

No abstract available

Publication types

Letter

MeSH terms

Biomarkers
Disease Progression
Extracellular Matrix / metabolism*
Humans
Lymphoma, Non-Hodgkin / blood
Lymphoma, Non-Hodgkin / complications*
Lymphoma, Non-Hodgkin / metabolism*
Thrombophilia / blood
Thrombophilia / etiology*
Thrombophilia / metabolism*

Substances

Biomarkers